A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

NCT00789399 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

78

Enrollment

INDUSTRY

Sponsor class

Stopped Principal Investigator moved to another region of the country

Conditions

Deep Vein Thrombosis
Coronary Artery Bypass Surgery
Venous Thromboembolism

Interventions

DRUG: Fondaparinux
OTHER: Placebo

Sponsor

Prairie Education and Research Cooperative

Collaborators

[object Object]